Submission of the drug for FDA approval for weight loss is expected after completion of a second phase 3 trial, SURMOUNT-2, in spring 2023
10.3390/ph17111543 7 AringerM.DistlerO.Hoffmann-VoldA.-M.KuwanaM.ProschH.VolkmannE
Jennifer Jose-Cappola, MD offers personalized antioxidant injections in the New York, Connecticut, and New England, Connecticut area
What Happens When Recycling Slows Down In patients, the enzyme GR, which is responsible for recycling spent/oxidised glutathione back to fully loaded, slows down, which leads to the accumulation of oxidised glutathione (GSSG) and the depletion and inability to produce GSH
Our results aligned with previous studies showing rates of thyroid cancer for females are around double the rates for males for both insulin and GLP-1 RA patients, as shown in Figure 3